Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus

This study investigated the real-world efficacy and safety of insulin degludec/insulin aspart (IDegAsp) in Korean adults with type 2 diabetes mellitus (T2DM), whose insulin treatment was switched to IDegAsp. This was a multicenter, retrospective, observational study comprising two 26-week treatment...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes & metabolism journal 2024, 48(5), 205, pp.929-936
Main Authors: Kang, Shinae, Ahn, Yu-Bae, Oh, Tae Keun, Lee, Won-Young, Chun, Sung Wan, Bae, Boram, Dahaoui, Amine, Jeong, Jin Sook, Jung, Sungeun, Jang, Hak Chul
Format: Article
Language:English
Subjects:
databases, factual
diabetes mellitus, type 2
glycemic control
hypoglycemia
insulin degludec, insulin aspart drug combination
Original
내과학
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study investigated the real-world efficacy and safety of insulin degludec/insulin aspart (IDegAsp) in Korean adults with type 2 diabetes mellitus (T2DM), whose insulin treatment was switched to IDegAsp. This was a multicenter, retrospective, observational study comprising two 26-week treatment periods, before and after switching to IDegAsp, respectively. Korean adults with uncontrolled T2DM treated with basal or premix insulin (±oral antidiabetic drugs) were enrolled. The primary objective was to compare the degree of glycosylated hemoglobin (HbA1c) change in each 26-week observation period. The analyses included changes in HbA1c, fasting plasma glucose (FPG), body weight, proportion of participants achieving HbA1c
ISSN:2233-6079
2233-6087
2233-6087
DOI:10.4093/dmj.2023.0297